Rani Therapeutics Holdings Inc (NASDAQ: RANI) on Monday, plunged -1.28% from the previous trading day, before settling in for the closing price of $2.34. Within the past 52 weeks, RANI’s price has moved between $1.82 and $8.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 83.82%. The company achieved an average annual earnings per share of 7.44%. With a float of $20.75 million, this company’s outstanding shares have now reached $26.04 million.
Let’s determine the extent of company efficiency that accounts for 140 employees. In terms of profitability, gross margin is 56.07%, operating margin of -2103.53%, and the pretax margin is -2200.98%.
Rani Therapeutics Holdings Inc (RANI) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rani Therapeutics Holdings Inc is 35.74%, while institutional ownership is 6.06%. The most recent insider transaction that took place on Oct 15 ’24, was worth 10,141,674. In this transaction 10% Owner of this company sold 3,829,360 shares at a rate of $2.65, taking the stock ownership to the 8,302,194 shares. Before that another transaction happened on Nov 24 ’23, when Company’s 10% Owner sold 5,265,165 for $2.01, making the entire transaction worth $10,582,982. This insider now owns 8,400 shares in total.
Rani Therapeutics Holdings Inc (RANI) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.36 earnings per share (EPS) for the period topping the consensus outlook (set at -0.37) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.40% during the next five years compared to 0.28% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
Rani Therapeutics Holdings Inc (RANI) is currently performing well based on its current performance indicators. A quick ratio of 1.93 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.03 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Looking closely at Rani Therapeutics Holdings Inc (NASDAQ: RANI), its last 5-days average volume was 1.26 million, which is a jump from its year-to-date volume of 0.55 million. As of the previous 9 days, the stock’s Stochastic %D was 16.53%. Additionally, its Average True Range was 0.35.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 9.17%, which indicates a significant decrease from 16.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 284.55% in the past 14 days, which was higher than the 128.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.53, while its 200-day Moving Average is $3.71. However, in the short run, Rani Therapeutics Holdings Inc’s stock first resistance to watch stands at $2.52. Second resistance stands at $2.73. The third major resistance level sits at $2.90. If the price goes on to break the first support level at $2.14, it is likely to go to the next support level at $1.97. Now, if the price goes above the second support level, the third support stands at $1.76.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
Market capitalization of the company is 74.59 million based on 50,420K outstanding shares. Right now, sales total 0 K and income totals -33,970 K. The company made 0 K in profit during its latest quarter, and -6,810 K in sales during its previous quarter.
